Cancer is a leading cause of death by disease in children and the second most prevalent of all causes in adults. Testicular germ cell tumors (TGCTs) make up 0.5% of pediatric malignancies, 14% of adolescent malignancies, and are the most common of malignancies in young adult men. Although the biology and clinical presentation of adult TGCTs share a significant overlap with those of the pediatric group, molecular evidence suggests that TGCTs in young children likely represent a distinct group compared to older adolescents and adults. The rarity of this cancer among pediatric ages is consistent with our current understanding, and few studies have analyzed and compared the molecular basis in childhood and adult cancers. Here, we review the major similarities and differences in cancer genetics, cytogenetics, epigenetics, and chemotherapy resistance between pediatric and adult TGCTs. Understanding the biological and molecular processes underlying TGCTs may help improve patient outcomes, and fuel further investigation and clinical research in childhood and adult TGCTs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152248 | PMC |
| http://dx.doi.org/10.3390/cancers13102349 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- Testicular germ cell tumours (TGCT) are the most common cancers found in young men, including seminoma and non-seminoma types.
- This study uses whole genome sequencing to analyze adult TGCTs, providing a detailed genomic profile that includes mutations, structural variations, and DNA amplifications.
- The research uncovers correlations between genetic changes and the different growth patterns of TGCT subtypes, highlighting late genomic duplication in some cases and a common immune disruption mechanism in seminomas.
Dysgerminomas: germ cell tumors exhibit high expression of PD-L1 and associated with high TILs and good prognosis.
Sci Rep
October 2024
Department of Medical Oncology, King Fahad Specialist Hospital, Eastern Health Cluster, Dammam, Saudi Arabia.
Article Synopsis
- - Ovarian germ cell tumors (OVGCTs) represent 28% of ovarian cancers in Saudi Arabia, with malignant types having a 13% diagnosis rate; patients with recurrent tumors often face a grim prognosis due to aggressive characteristics.
- - This study uniquely investigates PD-L1 expression in OVGCTs, analyzing samples from 34 tumors to understand its role in the tumor microenvironment, immune cell presence, and cancer stem cells' relation to overall clinical outcomes.
- - Results show that dysgerminomas have higher PD-L1 levels than yolk sac tumors, correlating with greater immune cell infiltration and better prognoses, contributing to the potential for immunotherapy in ovarian cancer treatment.
Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator .
Mol Med Rep
December 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo 14784400, Brazil.
Germ cell tumors (GCTs) constitute diverse neoplasms arising in the gonads or extragonadal locations. Testicular GCTs (TGCTs) are the predominant solid tumors in adolescents and young men. Despite cisplatin serving as the primary therapeutic intervention for TGCTs, 10‑20% of patients with advanced disease demonstrate resistance to cisplatin‑based chemotherapy, and epithelial‑mesenchymal transition (EMT) is a potential contributor to this resistance.
View Article and Find Full Text PDFLymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection.
Urol Oncol
December 2024
Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Article Synopsis
- The study investigates the effectiveness of primary retroperitoneal lymph node dissection (pRPLND) as a treatment for testicular germ cell tumors, focusing on lymph node density (LND) as a potential predictor for relapse.
- A total of 178 patients were reviewed, with 77% showing nodal metastasis, but the study found no significant link between LND and relapse-free survival, despite identifying an optimal LND threshold of 26.75%.
- The conclusion states that LND is not a reliable prognostic marker for relapse after pRPLND in testicular germ cell tumors, highlighting the unique characteristics of these tumors.
Multiportal Arthroscopy-assisted Surgical Resection of Diffuse-type Tenosynovial Giant Cell Tumors in the Ankle Joint Yields Favorable Clinical Outcomes: A Retrospective Study.
Orthop Surg
November 2024
Sports Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
Article Synopsis
- * The study involved analyzing data from 33 patients who underwent the treatment between 2011 and 2020, focusing on outcomes like pain scores, functional scores, and recurrence rates.
- * Results showed that most patients experienced significant symptom relief with only a small recurrence rate, and there were no notable differences in outcomes between two surgical approaches used in the study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!